Product Information
NIACIN ER 500 MG TABLET is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $0.1929 per EA under NDC 33342018710. Its NADAC has been published 172 times since Jun 21, 2023.
FDA first approved this application on Mar 3, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
500 mg/1
Manufacturer
Macleods Pharmaceuticals LimitedNDC
33342018710
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
NIACINApproval Type
Generic (ANDA)
FDA Application
ANDA204934FDA Approved
3/3/2022
TE Code
AB
On Market Since
3/3/2022
Pharmacological Classes
Price Statistics
The NADAC for NIACIN ER 500 MG TABLET has been published 172 times since Jun 21, 2023, and over the history we have for it it has declined 11.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1929 per EA |
|---|---|
| All-time high | $0.2223 (Dec 13, 2023) |
| All-time low | $0.1043 (Jul 17, 2024) |
| 52-week high | $0.1929 |
| 52-week low | $0.1492 |
| Median price | $0.1651 |
| Average price | $0.1651 |
| Largest weekly change | +51.4% (Aug 21, 2024) |
| Weeks tracked | 172 |
| Tracking since | Jun 21, 2023 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Macleods Pharmaceuticals Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Niacin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nicotinic Acid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NIACIN ER 500 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for NIACIN ER 500 MG TABLET, manufactured by Macleods Pharmaceuticals Limited, is $0.1929 per EA (NDC 33342018710), effective Sep 30, 2026.
How has the price of NIACIN ER 500 MG TABLET changed over time?
Over the history we have for it, the NADAC for NIACIN ER 500 MG TABLET has declined 11.0%. It has been tracked across 172 weekly CMS publications since Jun 21, 2023.
What are the highest and lowest recorded NADAC prices for NIACIN ER 500 MG TABLET?
Since Jun 21, 2023, the NADAC for NIACIN ER 500 MG TABLET has ranged from a low of $0.1043 (Jul 17, 2024) to a high of $0.2223 (Dec 13, 2023), with a median of $0.1651 per EA.
Are there cheaper alternatives to NIACIN ER 500 MG TABLET?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as NIACIN ER 500 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures NIACIN ER 500 MG TABLET?
NIACIN ER 500 MG TABLET (NDC 33342018710) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.